To determine the clinical manifestations and interfamilial variability of patients diagnosed with a mitochondrial cardiomyopathy, we reviewed the charts of 14 patients with cardiomyopathy out of 59 patients with mitochondrial disorders who attended the mitochondrial disease clinic at Wolfson Medical Center from 1996 to 2001. All patients underwent a metabolic evaluation including blood lactate, pyruvate, carnitine, and amino acids and urine organic acids. Respiratory chain enzymes were assessed in 10 patients. The mitochondrial DNA (mtDNA) was assessed for mutations.
The age at presentation ranged between 6 months and 24 years. Six of the patients died, 5 from heart failure. The cardiomyopathy was hypertrophic in 10 and dilated in 4. Conduction and rhythm abnormalities were present in 6. Eleven patients had family members with mitochondrial disorders. All the patients had additional involvement of one or more systems. Seven patients exhibited a deficiency of a respiratory chain enzyme in the muscle. The MELAS mtDNA point mutation (3243) was found in one patient. Blood lactic acid levels were increased in 5. Brain MRI abnormalities were observed in 4.
Mitochondrial dysfunction frequently affects the heart and may cause both hypertrophic and dilated cardiomyopathy. The cardiomyopathy is usually a part of a multisystem involvement and may rarely be isolated. The course may be stable for many years, but rapid deterioration may occur. Understanding the biochemical and genetic features of these diseases will enable us to comprehend the clinical heterogeneity of these disorders.
Hypertrophic cardiomyopathy Dilated cardiomyopathy Mitochondrial DNA
Marin-Garcia, J, Ananthakrishnan, R, Goldenthal, MJ, Filiano, JJ, Perez-Atayde, 1999Mitochondrial dysfunction in skeletal muscle of children with cardiomyopathy.Pediatrics103456459CrossRefPubMedGoogle Scholar
Marin-Garcia, J, Ananthakrishnan, R, Goldenthal, MJ, Pierpont, ME 2000Biochemical and molecular basis for mitochondrial cardiomyopathy in neonates and children.J Inherit Metab Dis23625633CrossRefPubMedGoogle Scholar
Munnich, A, Rotig, A, Chretien, D, Saudubray, JM, Cormier, V, Rustin, P 1996Clinical presentations of mitochondrial disorders in childhood.Eur J Pediatr155262274CrossRefPubMedGoogle Scholar
Nissenkorn, A, Zeharia, A, Lev, D, et al. 1999Multiple presentations of mitochondrial disorders.Arch Dis Child81209214PubMedGoogle Scholar
Rahman, S, Blok, RB, Dahl, HH, et al. 1996Leigh Syndrome: clinical features and biochemical and DNA abnormalities.Ann Neurol39343351PubMedGoogle Scholar
Rahman, S, Lake, BD, Taanman, JW, et al. 2000Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms.Brain123591600CrossRefPubMedGoogle Scholar
Rustin, P, Chretien, D, Bourgeron, T, et al. 1994Biochemical and molecular investigations in respiratory chain deficiencies.Clin Chim Acta2283551CrossRefPubMedGoogle Scholar
Rustin, P, Lebidois, J, Chretien, D, et al. 1994Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies.J Pediatr124224228PubMedGoogle Scholar
Santorelli, FM, Tessa, A, D’amati, G, Casali, C 2001The emerging concept of mitochondrial cardiomyopathies.Am Heart J141E1CrossRefPubMedGoogle Scholar
Shoffner, J, Wallace, D 1990Oxidative phosphorylation diseases. Disorders of two genomes.Adv Hum Genet19267330PubMedGoogle Scholar
Tiranti, V, Hoertnagel, K, Carrozzo, R, et al. 1998Mutations of SURF-1 in Leigh syndrome associated with cytochrome c oxidase deficiency.Am J Hum Genet6316091621CrossRefPubMedGoogle Scholar
Tulinius, MH, Holme, E, Kristiansson, B, Larsson, NG, Oldfors, A 1991Mitochondrial encephalomyopathies in childhood. II. Clinical manifestations and syndromes.J Pediatr119251259PubMedGoogle Scholar
Valnot, I, Kleist-Retzow, JC, Barrientos, A, et al. 2000A mutation in the human heme A: farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency.Hum Mol Genet912451249CrossRefPubMedGoogle Scholar